Why the study?
Although modern clinical trials and experimental research support traditional Chinese medicine for ACS prevention and treatment, the level of evidence and proper application remained barely satisfactory.
Does traditional Chinese medicine improve clinical manifestations and objective parameters in patients with acute coronary syndrome?
Population
Patients with ACS across unstable angina, acute myocardial infarction, and post myocardial infarction
Comparison
Traditional Chinese medicine intervention vs control
Design
Systematic review and meta-analysis of randomized controlled trials
Authors
Loading...
Supports TCM adjunctive benefit across ACS stages; extends prior data but leaves open need for rigorous long-term RCTs.
Does traditional Chinese medicine improve clinical manifestations and objective parameters in patients with acute coronary syndrome?
Traditional Chinese medicine may improve clinical and objective parameters, including CRP and LVEF, and reduce short-term cardiovascular events in patients with acute coronary syndrome.
Liao et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: